Skip to content

The impact of raw potato on the prevention of certain digestive problem.

The impact of raw potato on the prevention of certain digestive complications in mechanically ventilated patients admitted to intensive care unit

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016051127853N1
Enrollment
60
Registered
2016-12-13
Start date
2016-07-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal bleeding and non-bleeding side effects. Other functional intestinal disorders, Gastritis and duodenitis

Interventions

Intervention 1: Intervention group: 30 ml raw potatoe juice (raw potato with skin completely soft and filtered by the food processor to soften the material is passed directly gavage) with 20 ml of wat
Prevention
Intervention group: 30 ml raw potatoe juice (raw potato with skin completely soft and filtered by the food processor to soften the material is passed directly gavage) with 20 ml of water twice a day f
Control group: 20 mL of water twice a day for 5 days will be provided

Sponsors

Vice Chancellor for research of Zanjan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Objective: This clinical trial aims to reduce gastrointestinal side effects in patients, hospitalized in the intensive care unit. Design: This is a randomized , double-blind study in two groups of patients admitted to the intensive care unit in Mousavi Hospital, Zanjan done in 1395. Block non-probability sampling will be done in ventilated patients . To blind the study of two trained nurses (for gavage potatoes and outcome evaluation) will be used. to unify the severity in two groups ,the APACHE II scale was used. Interventions: In the first 24 hours, the patients divided in two groups and fed with standard and the same formula . After the second day of feeding the intervention group and 30 ml extract raw potatoes along with 20 cc of water per dose and control group 20 ml of water at every turn twice a day , 30 minutes before the feeding for 5 days. The main outcome variable: Before the start of each day during the intervention and control group (5 days) gastrointestinal side effects, including gastrointestinal bleeding and non-bleeding gastrointestinal complications will be cheeked. before every gavage , before the intervention and every day during the intervention .

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Gastric residual volume. Timepoint: 4 hours after each feeding. Method of measurement: Through a stomach tube stays in the stomach with a 60 cc syringe.;Feeding intolerance. Timepoint: 4 hours after a meal. Method of measurement: Increased gastric residual volume of more than 200 cc.;Vomiting. Timepoint: 4 hours after each feeding. Method of measurement: Exit or enter the gastrointestinal tract and gastric contents into the mouth and trachea.;Diarrhea. Timepoint: 4 hours after each feeding. Method of measurement: Asking from the patients or rely on records.;Constipation. Timepoint: 4 hours after each feeding. Method of measurement: Asking from the patients or rely on records.;Abdominal distention. Timepoint: 4 hours after each feeding. Method of measurement: Touch the belly and (reviewed create rigidity and guarding) and percussion abdomen (hearing).;Coffee ground. Timepoint: 4 hours after each feeding. Method of measurement: Through observation by the researcher or the records.;Melena. Timepoint: 4 hours after each feeding. Method of measurement: Through observation by the researcher or the records.;Hematemesis. Timepoint: 4 hours after each feeding. Method of measurement: Observed by the investigator or based on the the records.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarahnaz Mohammadkhaniha

Zanjan University of Medical Sciences

fmohammadkhaniha.nurse92@gmail.com+98 24 3342 4766

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026